OUROFINO S/A (OFSA3) Main Indicators
Basic Data - OFSA3
Company | OUROFINO S/A |
Corporate Name | OURO FINO SAUDE ANIMAL PARTICIPACOES S.A. |
Registration Status | ATIVO |
Issuer Status | FASE OPERACIONAL |
Listing Segment | Novo Mercado |
Activity | Atividade de comercialização de produtos destinados ao setor de saúde animal. |
Share | OFSA3 |
Quote Date | 09/18/2024 |
Share Type | ON |
Last Closing | R$ 21.91 |
Quotation Factor | 1 Share |
Financial Volume | R$ 19.72 thousand |
Last Statement | ITR - 06/30/2024 |
Sector | Saúde |
Subsector | Medicamentos e Outros Produtos |
Segment | Medicamentos e Outros Produtos |
Participation Indexes | IGC, IGNM, ITAG |
Updated 09/19/2024 |
Relative Prices - OFSA3
Price/Earnings | 22.06 |
Price/SBV | 1.71 |
Price/Net Sales | 1.26 |
Price/CFO | 7.75 |
Price/FCF | 8.30 |
Price/Total Assets | 0.90 |
Price/EBIT | 10.92 |
Price/Working Capital | 2.09 |
Price/NCAV | -23.01 |
EV/EBIT | 11.54 |
EV/EBITDA | 8.60 |
EV/Net Sales | 1.33 |
EV/CFO | 8.19 |
EV/FCF | 8.77 |
EV/Total Assets | 0.96 |
Company Market Cap | R$ 1.18 B |
Enterprise Value | R$ 1.25 B |
Current Financial Statement Date | 06/30/2024 |
Current Share Price | R$ 21.91 |
Share Price Date | 09/18/2024 |
Dividend Yield | 2.80% |
Updated 09/19/2024 |
Income Statement - OFSA3
Net Revenue | R$ 939.87 M |
Gross Result | R$ 439.10 M |
EBIT | R$ 108.26 M |
Depreciation and Amortization | - R$ 37.06 M |
EBITDA | R$ 145.32 M |
Net Profit | R$ 53.58 M |
Net Profit/Share | R$ 0.99 |
Updated 08/21/2024 |
Net Revenue | R$ 217.21 M |
Gross Result | R$ 104.61 M |
EBIT | R$ 26.26 M |
Depreciation and Amortization | - R$ 8.95 M |
EBITDA | R$ 29.66 M |
Net Profit | R$ 16.90 M |
Profit/Share | R$ 0.31 |
Updated 08/21/2024 |
Price and Volume Behavior - OFSA3
Lowest Price 52 weeks | R$ 17.72 |
Highest Price 52 weeks | R$ 25.60 |
Variation 2024 | -10.75% |
Variation 1 year | 3.25% |
Variation 2 years(total) | 4.38% |
Variation 2 years(yearly) | 2.16% |
Variation 3 years(total) | -17.82% |
Variation 3 years(yearly) | -6.32% |
Variation 4 years(total) | -16.81% |
Variation 4 years(yearly) | -4.49% |
Variation 5 years(total) | -38.67% |
Variation 5 years(yearly) | -9.31% |
Average Daily Volume (3 months) | R$ 95.43 thousand |
Updated 09/19/2024 |
Returns and Margins - OFSA3
Return on Initial Tangible Capital | 9.83% |
Return on Initial Invested Capital | 8.87% |
Pre-Tax Return on Initial Tangible Capital | 14.89% |
Pre-Tax Return on Initial Invested Capital | 13.43% |
Return on Initial Shareholder´s Equity | 8.06% |
Return on Initial Asset | 4.12% |
Gross Margin | 46.72% |
Net Margin | 5.70% |
EBIT Margin | 11.52% |
EBITDA Margin | 15.46% |
Initial Asset Turnover | 0.72 |
Financial Leverage | 1.90 |
Liabilities/Net Worth | 0.90 |
Net Debt/EBITDA | 0.46 |
Updated 08/21/2024 |
Balance Sheet - OFSA3
Cash and Cash Equivalents | R$ 343.25 M |
Total Assets | R$ 1.31 B |
Short-Term Debt | R$ 96.51 M |
Long-Term Debt | R$ 314.28 M |
Gross Debt | R$ 410.79 M |
Net Debt | R$ 67.55 M |
Shareholder´s Equity | R$ 689.47 M |
Share Book Value | R$ 12.78 |
Common Shares | 53,949,006 |
Preferred Shares | 0 |
Total | 53,949,006 |
Common Shares in Treasury | 181,400 |
Preferred Shares in Treasury | 0 |
Total in Treasury | 181,400 |
Common Shares (Except Treasury) | 53,767,606 |
Preferred Shares (Except Treasury) | 0 |
Total (Except Treasury) | 53,767,606 |
Updated 08/21/2024 |
Cash Flow - OFSA3
Operating Cash Flow | R$ 152.59 M |
Cash Flow from Investments | - R$ 38.06 M |
Financing Cash Flow | - R$ 34.29 M |
Increase (Reduction) in Cash and Equivalents | R$ 81.12 M |
Updated 08/21/2024 |
Operating Cash Flow | R$ 32.50 M |
Cash Flow from Investments | - R$ 7.22 M |
Financing Cash Flow | - R$ 31.80 M |
Increase (Reduction) in Cash and Equivalents | - R$ 6.01 M |
Updated 08/21/2024 |
Experimental - OFSA3
CAPEX 3 months | - R$ 1.46 M |
Free Cash Flow 3 months | R$ 31.04 M |
CAPEX 12 months | - R$ 10.17 M |
Free Cash Flow 12 months | R$ 142.42 M |
Updated 08/21/2024 |